Volume 27, Number 8—August 2021
Research
Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing
Figure 3

Figure 3. Ct values of self-collected and healthcare worker–collected samples for N1 target of severe acute respiratory syndrome coronavirus 2 PCR, Atlanta, Georgia, USA. PCR completed using CDC 2019-nCoV Real-Time Reverse Transcriptase PCR Diagnostic Panel (15). Horizontal lines within boxes indicate medians; box tops and bottoms indicate 25th and 75th percentiles; whiskers indicate the range. ANS, anterior nasal swab; Ct, cycle threshold; NPS, nasopharyngeal swab.
References
- World Health Organization. COVID-19 weekly epidemiological update—27 January 2021. 2021 Jan 27 [cited 2021 Feb 9]. https://www.who.int/publications/m/item/weekly-epidemiological-update---27-january-2021
- Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19. 2021 [cited 2021 Jan 29]. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html
- Tu Y-P, Jennings R, Hart B, Cangelosi GA, Wood RC, Wehber K, et al. Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med. 2020;383:494–6. DOIPubMedGoogle Scholar
- McCormick-Baw C, Morgan K, Gaffney D, Cazares Y, Jaworski K, Byrd A, et al. Saliva as an alternate specimen source for detection of SARS-CoV-2 in symptomatic patients using Cepheid Xpert Xpress SARS-CoV-2. J Clin Microbiol. 2020;58:e01109–20. DOIPubMedGoogle Scholar
- Procop GW, Shrestha NK, Vogel S, Van Sickle K, Harrington S, Rhoads DD, et al. A direct comparison of enhanced saliva to nasopharyngeal swab for the detection of SARS-CoV-2 in symptomatic patients. J Clin Microbiol. 2020;58:e01946–20. DOIPubMedGoogle Scholar
- Hanson KE, Barker AP, Hillyard DR, Gilmore N, Barrett JW, Orlandi RR, et al. Self-collected anterior nasal and saliva specimens versus health care worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2. J Clin Microbiol. 2020;58:e01824–20. DOIPubMedGoogle Scholar
- Payne DC, Smith-Jeffcoat SE, Nowak G, Chukwuma U, Geibe JR, Hawkins RJ, et al.; CDC COVID-19 Surge Laboratory Group. SARS-CoV-2 infections and serologic responses from a sample of U.S. Navy service members—USS Theodore Roosevelt, April 2020. MMWR Morb Mortal Wkly Rep. 2020;69:714–21. DOIPubMedGoogle Scholar
- Yousaf AR, Duca LM, Chu V, Reses HE, Fajans M, Rabold EM, et al. A prospective cohort study in nonhospitalized household contacts with severe acute respiratory syndrome coronavirus 2 infection: symptom profiles and symptom change over time. Clin Infect Dis. 2020 Jul 28 [Epub ahead of print].
- Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17:
e1003346 . DOIPubMedGoogle Scholar - Sun J, Xiao J, Sun R, Tang X, Liang C, Lin H, et al. Prolonged persistence of SARS-CoV-2 RNA in body fluids. Emerg Infect Dis. 2020;26:1834–8. DOIPubMedGoogle Scholar
- COVID-19 Investigation Team. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States. Nat Med. 2020;26:861–8. DOIPubMedGoogle Scholar
- Grady Health System. Grady fast facts. 2018 [cited 2021 Jan 29]. https://www.gradyhealth.org/wp-content/uploads/2018/07/Grady_Fast_Facts.pdf
- Centers for Disease Control and Prevention. How to collect your anterior nasal swab sample for COVID-19 testing. 2020 [cited 2021 Feb 12]. https://www.cdc.gov/coronavirus/2019-ncov/testing/How-To-Collect-Anterior-Nasal-Specimen-for-COVID-19.pdf
- Lu X, Wang L, Sakthivel SK, Whitaker B, Murray J, Kamili S, et al. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26:1654–65. DOIPubMedGoogle Scholar
- Boehmer TK, DeVies J, Caruso E, van Santen KL, Tang S, Black CL, et al. Changing age distribution of the COVID-19 pandemic—United States, May–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1404–9. DOIPubMedGoogle Scholar
- Council of State and Territorial Epidemiologists. Update to the standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19). 2020 [cited 2021 Jan 29]. https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf
- World Health Organization. RSV surveillance case definitions. 2020 [cited 2021 January 29]; https://www.who.int/influenza/rsv/rsv_case_definition/en
- Altamirano J, Govindarajan P, Blomkalns AL, Kushner LE, Stevens BA, Pinsky BA, et al. Assessment of sensitivity and specificity of patient-collected lower nasal specimens for severe acute respiratory syndrome coronavirus 2 testing [Erratum in: JAMA Netw Open. 2020;3: e2014910]. JAMA Netw Open. 2020;3:
e2012005 . DOIPubMedGoogle Scholar - Kojima N, Turner F, Slepnev V, Bacelar A, Deming L, Kodeboyina S, et al. Self-collected oral fluid and nasal swabs demonstrate comparable sensitivity to clinician-collected nasopharyngeal swabs for the detection of SARS-CoV-2. Clin Infect Dis. 2020; Epub ahead of print. DOIGoogle Scholar
- Butler-Laporte G, Lawandi A, Schiller I, Yao M, Dendukuri N, McDonald EG, et al. Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021;181:353–60. DOIPubMedGoogle Scholar
- Bastos ML, Perlman-Arrow S, Menzies D, Campbell JR. The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs: a systematic review and meta-analysis. Ann Intern Med. 2021;174:501–10. DOIPubMedGoogle Scholar
- Migueres M, Mengelle C, Dimeglio C, Didier A, Alvarez M, Delobel P, et al. Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers. J Clin Virol. 2020;130:
104580 . DOIPubMedGoogle Scholar - Tan SY, Tey HL, Lim ETH, Toh ST, Chan YH, Tan PT, et al. The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2. PLoS One. 2020;15:
e0244417 . DOIPubMedGoogle Scholar - Landry ML, Criscuolo J, Peaper DR. Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients. J Clin Virol. 2020;130:
104567 . DOIPubMedGoogle Scholar - Van Vinh Chau N, Lam VT, Dung NT, Yen LM, Minh NNQ, Hung LM, et al.; Oxford University Clinical Research Unit COVID-19 Research Group. The natural history and transmission potential of asymptomatic severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2020;71:2679–87. DOIPubMedGoogle Scholar
- Williams E, Bond K, Zhang B, Putland M, Williamson DA. Saliva as a noninvasive specimen for detection of SARS-CoV-2. J Clin Microbiol. 2020;58:e00776–20. DOIPubMedGoogle Scholar
- Salvatore PP, Dawson P, Wadhwa A, Rabold EM, Buono S, Dietrich EA, et al. Epidemiological correlates of polymerase chain reaction cycle threshold values in the detection of SARS-CoV-2. Clin Infect Dis. 2020;72:e761–7. DOIPubMedGoogle Scholar
- Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. [Erratum in: Nature. 2020;588:E35]. Nature. 2020;581:465–9. DOIPubMedGoogle Scholar
- Food and Drug Administration. Individual EUAs for molecular diagnostic tests for SARS-CoV-2. 2021 [cited 2021 Feb 2]. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-molecular
1Members are listed at the end of this article.